Pulmonary hypertension Historical Perspective: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 9: Line 9:
* The Historical Perspective of the PH is as follows:<ref name="pmid2700428">{{cite journal |vauthors=Smith DB |title=Continent diversions: an overview |journal=Dimens Oncol Nurs |volume=3 |issue=4 |pages=18–23 |date=1989 |pmid=2700428 |doi= |url=}}</ref><ref name="pmid14033007">{{cite journal |vauthors=KIRKENDALL WM, GIFFORD RW, HORWITZ D, WILSON WR, GOLDBERG LI, GROLLMAN A |title=General aspects of hypertension; past, present and future |journal=Postgrad Med |volume=34 |issue= |pages=150–6 |date=August 1963 |pmid=14033007 |doi= |url=}}</ref><ref name="pmid">{{cite journal |vauthors= |title= |journal= |volume= |issue= |pages= |date= |pmid= |doi= |url=}}</ref>
* The Historical Perspective of the PH is as follows:<ref name="pmid2700428">{{cite journal |vauthors=Smith DB |title=Continent diversions: an overview |journal=Dimens Oncol Nurs |volume=3 |issue=4 |pages=18–23 |date=1989 |pmid=2700428 |doi= |url=}}</ref><ref name="pmid14033007">{{cite journal |vauthors=KIRKENDALL WM, GIFFORD RW, HORWITZ D, WILSON WR, GOLDBERG LI, GROLLMAN A |title=General aspects of hypertension; past, present and future |journal=Postgrad Med |volume=34 |issue= |pages=150–6 |date=August 1963 |pmid=14033007 |doi= |url=}}</ref><ref name="pmid">{{cite journal |vauthors= |title= |journal= |volume= |issue= |pages= |date= |pmid= |doi= |url=}}</ref>
* In 1891 a German physician Ernst von Romberg described pulmonary vascular sclerosis in an autopsy.  
* In 1891 a German physician Ernst von Romberg described pulmonary vascular sclerosis in an autopsy.  
* In 1901 Abel Ayerza Key lecture integrating cyanosis and right heart failure, named the condition as “cardiac negro” (black cardiac)
* In 1901 Abel Ayerza Key lecture integrating cyanosis and right heart failure, named the condition as “cardiac negro”-black heart.
* In 1913 F. C. Arrillaga Syphilitic arteriosclerosis assigned as etiology of PH; changed the name of disease to “Ayerza’s Disease”
* In 1913 F. C. Arrillaga Syphilitic arteriosclerosis assigned as etiology of PH; changed the name of disease to “Ayerza’s Disease”
* In 1929 Werner Forssman demonstrated that it was possible to perform right sided catheterization in humans by performing catheterization on himself
* In 1929 Werner Forssman demonstrated that it was possible to perform right sided catheterization in humans by performing catheterization on himself.
* In 1951 David Dresdale coined the term primary pulmonary hypertension for the first time.
* In 1951 David Dresdale coined the term primary pulmonary hypertension for the first time.
* In 1956 Forssman, Cournand, Richards awarded Nobel Prize for their contributions to the discovery of circulatory and cardiopulmonary systems
* In 1956 Forssman, Cournand, Richards were awarded the Nobel Prize for their contributions to the discovery of circulatory and cardiopulmonary systems.
* In 1958 Paul Wood published Pulmonary Hypertension with special reference to the Vasoconstrictive Factor
* In 1958 Paul Wood published Pulmonary Hypertension with an association with a vasoconstrictive factor.
* In 1965–1970s First PPH epidemic related to the approval of Aminorex.
* In 1965–1970s first Pulmonary Hypertension epidemic related to the approval of Aminorex.
* In 1973 1st WHO Meeting in PH the landmark meeting about PPH; provided recommendations for future directions
* In 1973 1st WHO Meeting in PH the landmark meeting about Pulmonary Hypertension, provided recommendations for future directions
* In 1981 PPH Registry landmark multi-center U.S. study characterizing natural history and clinical features of PPH
* In 1981 PPH Registry landmark multi-center U.S. study characterizing natural history and clinical features of PPH.
* In 1996–1970s Second PPH epidemic the association between anorexigens and PH was first identified in the 1960s when an epidemic of PAH occurred in Europe that was linked to the anorexigens such as fenfluramine and dexfenfluramine.
* In 1996–1970s second Pulmonary Hypertension epidemic the association between anorexigens and PH was first identified in the 1960s when an epidemic of PAH occurred in Europe that was linked to the anorexigens such as fenfluramine and dexfenfluramine.
* In 1998 2nd World Symposium on PH formation of Evian Classification of PH; introduction of term “pulmonary arterial hypertension”, PAH
* In 1998 2nd World Symposium on PH formation of Evian Classification of PH and the term pulmonary arterial hypertension (PAH) was coined.
* In 2003 3rd World Symposium on PH Venice Classification; idiopathic PAH introduced to replace term PPH
* In 2003 3rd World Symposium on PH Venice Classification; idiopathic PAH introduced to replace term PPH
* In 2008 4th World Symposium on PH Dana Point Classification; modification of genetic category, among others in Group 1
* In 2008 4th World Symposium on PH Dana Point Classification; modification of genetic category, among others in Group 1
* In 2013 5th World Symposium on PH Nice Classification; further modifications of genetic category, among others in Group 1
* In 2013 5th World Symposium on PH Nice Classification; further modifications of genetic category, among others in Group 1
* In 2014 International Right Heart Failure Foundation Working Group development of a comprehensive nomenclature of right heart failure: defining distinction between right heart failure and right ventricular failure, components of right heart system, and definition of right heart failure
* In 2014 International Right Heart Failure Foundation- comprehensive nomenclature of RHF (Right Heart Failure) defining distinction between right heart failure vs right ventricular failure vs components of right heart system, and the definition of right heart failure


==References==
==References==

Revision as of 19:12, 1 March 2018

Pulmonary Hypertension Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pulmonary hypertension from other Diseases

Epidemiology & Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History & Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pulmonary hypertension Historical Perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Google Images

American Roentgen Ray Society Images of Pulmonary hypertension Historical Perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pulmonary hypertension Historical Perspective

CDC on Pulmonary hypertension Historical Perspective

Pulmonary hypertension Historical Perspective in the news

Blogs on Pulmonary hypertension Historical Perspective

Directions to Hospitals Treating Pulmonary hypertension

Risk calculators and risk factors for Pulmonary hypertension Historical Perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

In 1891 a German physician Ernst von Romberg described pulmonary vascular sclerosis in an autopsy. In 1951 David Dresdale coined the term primary pulmonary hypertension for the first time.

Historical Perspective

  • The Historical Perspective of the PH is as follows:[1][2][3]
  • In 1891 a German physician Ernst von Romberg described pulmonary vascular sclerosis in an autopsy.
  • In 1901 Abel Ayerza Key lecture integrating cyanosis and right heart failure, named the condition as “cardiac negro”-black heart.
  • In 1913 F. C. Arrillaga Syphilitic arteriosclerosis assigned as etiology of PH; changed the name of disease to “Ayerza’s Disease”
  • In 1929 Werner Forssman demonstrated that it was possible to perform right sided catheterization in humans by performing catheterization on himself.
  • In 1951 David Dresdale coined the term primary pulmonary hypertension for the first time.
  • In 1956 Forssman, Cournand, Richards were awarded the Nobel Prize for their contributions to the discovery of circulatory and cardiopulmonary systems.
  • In 1958 Paul Wood published Pulmonary Hypertension with an association with a vasoconstrictive factor.
  • In 1965–1970s first Pulmonary Hypertension epidemic related to the approval of Aminorex.
  • In 1973 1st WHO Meeting in PH the landmark meeting about Pulmonary Hypertension, provided recommendations for future directions
  • In 1981 PPH Registry landmark multi-center U.S. study characterizing natural history and clinical features of PPH.
  • In 1996–1970s second Pulmonary Hypertension epidemic the association between anorexigens and PH was first identified in the 1960s when an epidemic of PAH occurred in Europe that was linked to the anorexigens such as fenfluramine and dexfenfluramine.
  • In 1998 2nd World Symposium on PH formation of Evian Classification of PH and the term pulmonary arterial hypertension (PAH) was coined.
  • In 2003 3rd World Symposium on PH Venice Classification; idiopathic PAH introduced to replace term PPH
  • In 2008 4th World Symposium on PH Dana Point Classification; modification of genetic category, among others in Group 1
  • In 2013 5th World Symposium on PH Nice Classification; further modifications of genetic category, among others in Group 1
  • In 2014 International Right Heart Failure Foundation- comprehensive nomenclature of RHF (Right Heart Failure) defining distinction between right heart failure vs right ventricular failure vs components of right heart system, and the definition of right heart failure

References

  1. Smith DB (1989). "Continent diversions: an overview". Dimens Oncol Nurs. 3 (4): 18–23. PMID 2700428.
  2. KIRKENDALL WM, GIFFORD RW, HORWITZ D, WILSON WR, GOLDBERG LI, GROLLMAN A (August 1963). "General aspects of hypertension; past, present and future". Postgrad Med. 34: 150–6. PMID 14033007.
  3. Empty citation (help)

Template:WH Template:WS